Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)
|Human Immunodeficiency Virus|
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Redistribution and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)|
|Study Start Date:||January 2005|
|Study Completion Date:||May 2007|
|Primary Completion Date:||May 2007 (Final data collection date for primary outcome measure)|
|HIV Positive FRAM 1 Participant|
This research is being done to learn whether HIV-infected patients have abnormalities in their blood vessels that could eventually lead to heart attack or stroke (atherosclerosis), in how fat is distributed in their body and in how their body handles fat and sugars. If there are abnormalities, this study will also try to find out what factors may contribute to those abnormalitites.
People who participated in FRAM 1 may join FRAM 2.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00244803
|United States, Maryland|
|Johns Hopkins University, The Clinical Trials Unit|
|Baltimore, Maryland, United States, 21205|
|Principal Investigator:||Joseph Cofrancesco Jr., M.D.||Johns Hopkins University|